Predict your next investment

HEALTHCARE | Drug Manufacturing / Generics

See what CB Insights has to offer


Acquired | Acquired



About Cipla Medpro South Africa

Cipla Medpro South Africa is a generic manufacturer.

Cipla Medpro South Africa Headquarter Location

Mispel Street Bellville

Cape Town, 7530,

South Africa

+27 219434200

Latest Cipla Medpro South Africa News

Cipla share price rises on distribution agreement for antipsychotic drug

Feb 11, 2020

Cipla share price rises on distribution agreement for antipsychotic drug The transaction allows Cipla Medpro to market and distribute the Medicine in South Africa and neighbouring countries. × Cipla share price rose over 1 percent after the company's subsidiary entered into an agreement for an antipsychotic drug. Cipla Medpro South Africa (Pty), a wholly-owned subsidiary of Cipla and South Africa’s third-largest pharmaceutical company in the private sector, has recently concluded an exclusive agreement securing originator and authorised generic brands of an atypical antipsychotic drug, Quetiapine. The agreement involves AstraZeneca Pharmaceuticals (Pty), the originator of the Quetiapine, and Luye Pharma Hong Kong, which acquired the assets and rights to the medicine in select territories.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.